US Patent 9956298 Pyrrolobenzodiazepines and conjugates thereof
Patent 9956298 was granted and assigned to Medimmune Limited on May, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+83 characters)
Article
Patent abstract
A compound which is selected from A: and salts and solvates thereof.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09956298 Pyrrolobenzodiazepines and conjugates thereof US Patent 9956298 Pyrrolobenzodiazepines and conjugates thereof
Infobox
Patent Number
0995629800
Patent Number
995629800
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
099562980
Date of Patent
May 1, 2018
0Patent Application Number
150285750
Date Filed
October 10, 2014
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
099562980
Date of Patent
May 1, 2018
0Patent Application Number
150285750
Date Filed
October 10, 2014
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09956298 Pyrrolobenzodiazepines and conjugates thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09956298
Date of patent
May 1, 2018
Patent application number
15028575
Date Filed
October 10, 2014
Patent primary examiner
Find more entities like US Patent 9956298 Pyrrolobenzodiazepines and conjugates thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
